Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from western Sweden.

Familial cancer - 1 Jan 2007

Einbeigi Zakaria, Bergman Annika, Meis-Kindblom Jeanne M, Flodin Anna, Bjursell Cecilia, Martinsson Tommy, Kindblom Lars-Gunnar, Wahlström Jan, Wallgren Arne, Nordling Margareta, Karlsson Per

Abstract excerpt

AIM: This study aimed to analyze whether the occurrence of both breast and ovarian cancer in a woman serves as a marker for BRCA gene mutations. MATERIAL AND METHODS: This population-based study included 256 women in western Sweden who developed both invasive breast and ovarian tumors between 1958 and 1999. Archival paraffin tissue blocks of their tumors were retrieved for DNA-extraction to analyze the founder...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Neoplasms, Second Primary

Share to Neoplastic Syndromes, Hereditary

Share to Ovarian Neoplasms

Share to Risk Assessment

Share to Sweden

Source

Identifiers

PMID: 16944270
DOI: 10.1007/s10689-006-9101-0

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from western Sweden.PMID 16944270Read ↗

BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.Semantic proximity Read ↗

A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer.Semantic proximity Read ↗

The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation.Semantic proximity Read ↗

BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark.Semantic proximity Read ↗

BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families.Semantic proximity Read ↗

Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status.Semantic proximity Read ↗

Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases.Semantic proximity Read ↗

BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study.Semantic proximity Read ↗

BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.Semantic proximity Read ↗

BRCA mutation testing and association with oncologic outcome and incidence of ovarian cancer in Norway.Semantic proximity Read ↗

Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA.Semantic proximity Read ↗

One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.